Michael Okunewitch
Stock Analyst at Maxim Group
(0.48)
# 4,215
Out of 4,983 analysts
378
Total ratings
38.1%
Success rate
-2.5%
Average return
Main Sectors:
Stocks Rated by Michael Okunewitch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCGN Ocugen | Reiterated: Buy | $8 | $1.03 | +676.70% | 24 | Sep 16, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $55 | $38.68 | +42.19% | 17 | Sep 15, 2026 | |
| EVAX Evaxion | Reiterated: Buy | $10 | $3.22 | +210.56% | 4 | Aug 26, 2026 | |
| KPRX Kiora Pharmaceuticals | Reiterated: Buy | $12 | $2.67 | +349.44% | 33 | Aug 20, 2026 | |
| RANI Rani Therapeutics Holdings | Reiterated: Buy | $5 | $0.8516 | +487.13% | 16 | Aug 20, 2026 | |
| VNRX VolitionRx | Reiterated: Buy | n/a | $0.2849 | - | 4 | Aug 17, 2026 | |
| BLTE Belite Bio | Reiterated: Buy | $200 | $170.35 | +17.41% | 14 | Aug 14, 2026 | |
| LGVN Longeveron | Reiterated: Hold | n/a | $2.71 | - | 25 | Aug 14, 2026 | |
| MDWD MediWound | Reiterated: Buy | $30 | $13.38 | +124.22% | 28 | Aug 14, 2026 | |
| ACRV Acrivon Therapeutics | Reiterated: Buy | $7 | $1.70 | +311.76% | 13 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.03 | +191.26% | 16 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $4 | $1.02 | +292.16% | 13 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $15.00 | +33.33% | 12 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $165 | $150.89 | +9.35% | 24 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.80 | +78.57% | 13 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $1.95 | +1,438.46% | 24 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | - | - | 2 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.49 | - | 8 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $12 | $2.27 | +428.63% | 2 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $2.66 | -62.34% | 23 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $1.73 | +767.05% | 7 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.36 | - | 6 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.5879 | - | 28 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6.9 | $1.84 | n/a | 6 | Sep 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.75 | n/a | 1 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.29 | n/a | 11 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.4819 | n/a | 4 | May 9, 2023 |
Ocugen
Sep 16, 2026
Reiterated: Buy
Price Target: $8
Current: $1.03
Upside: +676.70%
Definium Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $55
Current: $38.68
Upside: +42.19%
Evaxion
Aug 26, 2026
Reiterated: Buy
Price Target: $10
Current: $3.22
Upside: +210.56%
Kiora Pharmaceuticals
Aug 20, 2026
Reiterated: Buy
Price Target: $12
Current: $2.67
Upside: +349.44%
Rani Therapeutics Holdings
Aug 20, 2026
Reiterated: Buy
Price Target: $5
Current: $0.8516
Upside: +487.13%
VolitionRx
Aug 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.2849
Upside: -
Belite Bio
Aug 14, 2026
Reiterated: Buy
Price Target: $200
Current: $170.35
Upside: +17.41%
Longeveron
Aug 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.71
Upside: -
MediWound
Aug 14, 2026
Reiterated: Buy
Price Target: $30
Current: $13.38
Upside: +124.22%
Acrivon Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $7
Current: $1.70
Upside: +311.76%
Aug 11, 2026
Reiterated: Buy
Price Target: $3
Current: $1.03
Upside: +191.26%
Aug 10, 2026
Rated: Buy
Price Target: $4
Current: $1.02
Upside: +292.16%
Aug 7, 2026
Reiterated: Buy
Price Target: $20
Current: $15.00
Upside: +33.33%
Aug 6, 2026
Reiterated: Buy
Price Target: $165
Current: $150.89
Upside: +9.35%
Jul 13, 2026
Reiterated: Buy
Price Target: $5
Current: $2.80
Upside: +78.57%
Jun 24, 2026
Reiterated: Buy
Price Target: $30
Current: $1.95
Upside: +1,438.46%
May 21, 2026
Reiterated: Buy
Price Target: $5
Current: -
Upside: -
May 4, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.49
Upside: -
Apr 9, 2026
Rated: Buy
Price Target: $10 → $12
Current: $2.27
Upside: +428.63%
Apr 8, 2026
Reiterated: Buy
Price Target: $1
Current: $2.66
Upside: -62.34%
Mar 25, 2026
Reiterated: Buy
Price Target: $15
Current: $1.73
Upside: +767.05%
Mar 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.36
Upside: -
Sep 23, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.5879
Upside: -
Sep 13, 2025
Reiterated: Hold
Price Target: $6.9
Current: $1.84
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: $12
Current: $3.75
Upside: n/a
Sep 13, 2024
Reiterated: Buy
Price Target: $12
Current: $3.29
Upside: n/a
May 9, 2023
Reiterated: Buy
Price Target: n/a
Current: $0.4819
Upside: n/a